INTEGRATED BIOPHARMA INC Deferred Tax Assets, Capital Loss Carryforwards
INTEGRATED BIOPHARMA INC (INBP) had Deferred Tax Assets, Capital Loss Carryforwards of $678.00 thousand as of 2025-06-30, per its 10-K filed 2025-09-23.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross
us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2025-09-23
- 2025-06-30: Deferred Tax Assets, Capital Loss Carryforwards $678.00K.
- 2024-06-30: Deferred Tax Assets, Capital Loss Carryforwards $678.00K.
- 2023-06-30: Deferred Tax Assets, Capital Loss Carryforwards $678.00K.
- 2022-06-30: Deferred Tax Assets, Capital Loss Carryforwards $485.00K; Deferred Tax Assets, Capital Loss Carryforwards as first filed $299.00K.
| Period end | Deferred Tax Assets, Capital Loss Carryforwards | Deferred Tax Assets, Capital Loss Carryforwards as first filed |
|---|---|---|
| 2025-06-30 | $678.00K 10-K · filed 2025-09-23 | |
| 2024-06-30 | $678.00K 10-K · filed 2025-09-23 | |
| 2023-06-30 | $678.00K 10-K · filed 2024-09-20 | |
| 2022-06-30 | $485.00K 10-K · filed 2023-09-15 | $299.00K 10-K · filed 2022-09-13 |
| 2021-06-30 | $299.00K 10-K · filed 2022-09-13 | |
| 2020-06-30 | $258.00K 10-K · filed 2021-09-02 | |
| 2019-06-30 | $16.00K 10-K · filed 2020-09-23 | |
| 2018-06-30 | $21.00K 10-K · filed 2019-08-29 | |
| 2017-06-30 | $31.00K 10-K · filed 2018-09-12 | |
| 2016-06-30 | $31.00K 10-K · filed 2017-09-01 | |
| 2015-06-30 | $31.00K 10-K · filed 2016-09-02 | |
| 2013-06-30 | $1.15M 10-K · filed 2014-09-08 | |
| 2012-06-30 | $1.29M 10-K · filed 2013-09-30 | |
| 2011-06-30 | $1.29M 10-K · filed 2012-10-15 |